Pharma Leaders Interview

Siemens Healthineers, radiology, healthcare, technology, artificial intelligence,

‘AI and robotics will define new health,’ says Peter Schardt

Siemens Healthineers is advancing AI and robotics in healthcare to improve patient outcomes, enhance automation, and reduce costs with innovations…

Updated: March 31, 2025 17:56 IST

Empagliflozin, Empagliflozin generics, Empagliflozin Mankind Pharma, Rajeev Juneja, Glenmark Pharma, Alkem Labs, healthcare news, pharma news,

Mankind to sell its diabetes drug, Empagliflozin, for Rs 5, company expects 50% volume growth: Rajeev Juneja

On Wednesday, Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin…

March 12, 2025 13:56 IST

We plan to focus on high precision MedTech products to cater to global demand: Zydus Lifesciences MD

Amplitude Surgical has experienced significant growth over the last four years, driven by new product development, international growth, investments in…

March 11, 2025 15:47 IST

Indian pharma industry, pharma, drugs, healthcare, health, IDMA

Indian pharma and the case for tempered take on tariff gains for US

While the US is a $600 billion pharmaceutical market, the share of these generic is 90 per cent in terms…

February 18, 2025 14:12 IST

Consumer health, consumer health market, consumer health market India, Johnson and Johnson, Kenvue, healthcare news, pharma news,

We have made strategic choices for Indian market to grow, scale and meet unmet needs of consumers: Manish Anandani, MD, Kenvue India

In May 2023, Kenvue (erstwhile Johnson & Johnson Consumer Health) was listed on the New York Stock Exchange (NYSE) as…

December 3, 2024 16:23 IST

Various unment needs exist in Multiple Myeloma treatment; Our novel therapy's early data show remarkable response: Cyril Konto, President, Ichnos Glenmark Innovation

Various unmet needs exist in Multiple Myeloma treatment; Our novel therapy’s early data shows remarkable response: Cyril Konto, President, Ichnos Glenmark Innovation

If confirmed in clinical settings, this advantage could position ISB 2001 to leapfrog these approved therapies and expedite its path to…

November 26, 2024 21:15 IST

Prof Rachel Batterham, Senior VP, International Medical Affairs, Eli Lilly and Company

FE Exclusive | India is a priority market; We aim to launch tirzepatide for obesity in India by 2025: Prof Rachel Batterham, Senior VP, International Medical Affairs, Eli Lilly

Obesity is a chronic, progressive disease that can lead to serious health complications, reduced quality of life, and premature death,…

November 24, 2024 09:10 IST

India continues to be our biggest focus and priority; We want to democratise genomics: Dr Amit Kakar, Chairman of Board, MedGenome

MedGenome has been one of the key players in India’s genetic testing space and in the last one decade has…

November 24, 2024 08:03 IST

Pharmaceuticals, Lupin Manufacturing Solutions, Disease area, CDMO market, pharma news, FE exclusive, healthcare news,

FE Exclusive | We are planning to expand our therapeutic footprint in high-demand disease areas: Dr. Abdelaziz Toumi, CEO, Lupin Manufacturing Solutions

Lupin entered into the CDMO business last year in June with the launch of its new subsidiary Lupin Manufacturing Solutions…

November 12, 2024 12:19 IST

Glenmark Pharmaceuticals, Dermatology portfolio, skin disorders, skin disorders in India, healthcare news, Glenmark news, pharmaceuticals news,

We are continuously exploring opportunities to enhance our dermatology portfolio to address diverse needs: Alok Malik, President – India Formulations, Glenmark Pharma

Glenmark made its foray into the dermatology therapy area over four decades ago and has maintained a robust presence in…

October 24, 2024 16:08 IST

Medical Devices, Medical Devices industry, Medical devices industry of India, Poly medicure, healthcare news, medical devices news,

Around 80% medical devices coming from abroad; Reliance on import continues to be challenge: Himanshu Baid, MD, Poly Medicure

India’s Med-Tech industry is experiencing remarkable growth, but it does face certain challenges that, if effectively addressed, can enhance its…

October 15, 2024 11:17 IST

Children are more prone to severe complications like dengue shock syndrome, demanding greater vigilance and expertise: Dr. Naveen Thacker, President, International Pediatric Association

Dengue remains a major health challenge in India, with an estimated 33 million clinically apparent cases each year, accounting for…

September 24, 2024 18:21 IST

Consumer health, bayer consumer health, covid, covid pandemic, healthcare news,

FE Exclusive | Supradyn Naturals Calcium for calcium, vitamin D deficiencies to be launched soon: Sandeep Verma, India Country Head, Bayer Consumer Health

Under Verma’s leadership, the company has successfully launched its legacy brands, Saridon and Supradyn, which have become leading self-care products…

September 21, 2024 20:28 IST

Abortion, abortion rights in India, abortion facilities in India, health news, wellness news, women's health,

Only 1 in 3 people know that abortion is legal in India: Vinoj Manning, CEO, Ipas Development Foundation

Despite abortion being legal in India for the last 50 years, awareness about legality, safety and availability of abortion is…

September 8, 2024 13:40 IST

Cipla, Orchid Pharma, Antimicrobial Resistance, AMR, Pathogens, drug discovery, healthcare news,

India needs increased surveillance, more focus on drug discovery to combat AMR: Dr. Jaideep Gogtay, Global CMO, Cipla

It is noteworthy that AMR makes infections harder to treat and makes other medical procedures and treatments – such as…

August 2, 2024 17:04 IST

API, API market, API manufacturing market, API market of India, Supriya Lifescience, health news, pharma news,

Our primary goal is to double our revenue, enter higher-margin niche segments and increase footprint: Dr. Saloni Wagh, Director, Supriya Lifescience Ltd.

Our strategic goals include increasing our footprint in these regulated markets, enhancing our North American contributions, and expanding further in…

June 25, 2024 09:04 IST

Antimicrobial Resistance, AMR, AMR in India, healthcare news,

We are working on reviving its R&D strengths; To launch new products 1-2 months: Rajnish Rohatgi, CEO, Orchid Pharma

Drug discovery is an extremely complex, expensive and risky business, with very few of the possibilities being worked on resulting…

June 24, 2024 10:54 IST

There is a lack of awareness among couples regarding fertility treatments: Abhishek Aggarwal, CBO, Birla Fertility and India, C.K Birla Group

There is a lack of awareness among couples regarding fertility treatments: Abhishek Aggrawal, CBO, Birla Fertility and IVF, C.K Birla Group

To reverse the downward trend in fertility rates across the country, a multifaceted approach encompassing various economic policies and interventions…

June 17, 2024 11:00 IST

Related News

Ayushman Bharat scheme benefits: Families with senior citizens get Rs 10 lakh health cover — but there's a catch

Ayushman Bharat scheme: Families with parents above 70 get Rs 10 lakh health cover — but here’s a catch

An incorrect name on your Aadhaar can lead to severe issues with KYC (Know Your Customer) compliance, bank accounts, and benefits distribution.

Aadhaar card online update: How to change name, address, date of birth and phone number online in simple steps

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

Lenskart Solutions IPO Subscription Status, GMP price Live

LIVE: Big drop in Lenskart IPO GMP; Premium slips to 11% from peak – Check issue price and key details ahead of Oct 31 opening

‘I was so moved, I had…’: Yami Gautam recalls first time she read Ranveer Singh-starrer Dhurandhar script

Hyundai net rises 14% to Rs 1,572 cr

Business43 min ago

HMIL’s net profit rose by 14% in Q2 of FY26, thanks to better cost control and higher exports. Although revenue growth was only 1%, it exceeded expectations for both profit and revenue. The company’s Ebitda margin also increased due to increased exports and cost-cutting efforts. The stock remained steady but closed with a 2.4% gain, with the highly anticipated updated Venue model on the horizon.

View all shorts